Current role
Biotechnology · Healthcare
CFO, CEO
2023-12-04–present
John Cavan
Equibles does not estimate personal net worth.
Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get HEPA alertsAbout John Cavan
John Cavan is recorded as CEO at Hepion Pharmaceuticals, Inc. (HEPA) since December 4, 2023 and CFO at Hepion Pharmaceuticals, Inc. (HEPA). The newest filing on record that lists John Cavan as CFO at Hepion Pharmaceuticals, Inc. (HEPA) is dated April 28, 2023. Hepion Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2023 that John Cavan was appointed interim Chief Executive Officer, effective December 4, 2023. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), Kaouthar Lbiati (CEO and Board Member) and 7 others.
“On December 4, 2023, the Board of Directors appointed John Cavan, the Company's Chief Financial Officer, as interim Chief Executive Officer.”
Affiliation history
-
Current
2023-12-04–present
-
Current
Start not stated–present
Last confirmed April 28, 2023
Company network
Leadership on record at Hepion Pharmaceuticals, Inc.
- Dr. Kaouthar Lbiati CEO
- Gary Stetz CEO, CFO, Board Member
- Kaouthar Lbiati CEO, Board Member
- Sireesh Appajosyula CEO, Board Member
- John Brancaccio Chairman, CFO
- Vincent LoPriore Chairman
- Chase LoPriore Board Member
- Danina Fisher Board Member
- Gary S. Stetz, II Board Member
- James Liddy Board Member